FILTER CONTENT

Filters
Filters
Post Date
Company Names
Show (789)
Cancel

Research

  • By Published On: November 19, 2025

    Sell SEMrush Holdings

  • 7investing logo next to the Duolingo logo.
    By Published On: September 8, 2025

    Duolingo Holds Off GPT; Upgrading to “Strong Buy”

    Duolingo (Nasdaq: DUOL), the language-learning software provider, has been one of the best-performers [...]

  • Close up of keyboard with green "Sell" button
    By Published On: June 30, 2025

    7investing Exclusive: Sell These 4 Stocks

    On a trip to Colorado earlier this month, I was briefly stopped in [...]

  • By Published On: June 30, 2025

    Sell Wolfspeed

  • 7investing logo and Tandem Diabetes Care logo side by side.
    By Published On: June 30, 2025

    Sell Tandem Diabetes Care

  • 7investing logo next to the STAAR Surgical logo.
    By Published On: June 30, 2025

    Sell STAAR Surgical

  • 7investing logo next to the Electronic Arts logo.
    By Published On: June 30, 2025

    Sell Electronics Arts

  • 7investing logo next to the TaskUs logo.
    By Published On: June 3, 2025

    Sell TaskUs

  • By Published On: March 21, 2025

    Sell AEHR Test Systems

  • 7investing logo next to the Redfin logo.
    By Published On: March 21, 2025

    Sell Redfin

  • 7investing logo next to the Coherus BioSciences logo.
    By Published On: March 21, 2025

    Sell Coherus BioSciences

  • Fresh pizza with a slice being removed
    By Published On: February 24, 2025

    Dominos’ Cash Flow Dilemma: Are There Enough Slices to Feed Everyone?

    Domino's (Nasdaq: DPZ), the world's largest pizza chain, just reported its fourth quarter [...]

  • 7investing logo next to the Avita Medical logo.
    By Published On: February 17, 2025

    AVITA Medical: 2025 Will Be an “Inflection Point Year”

    AVITA Medical is continuing to show signs of progress. Its recently-reported fourth quarter [...]

  • 7investing logo next to the Veeva Systems logo.
    By Published On: February 17, 2025

    Veeva’s Slow-and-Steady Results Are Winning the Software Race; Shares Still a “Buy”

    Veeva's third quarter 2025 results demonstrated that its growth is continuing to slow, [...]

  • By Published On: November 26, 2024

    Sell Cassava Sciences

  • By Published On: November 20, 2024

    Sell Progyny